Literature DB >> 21191287

In-vivo detection of the frequency and distribution of thin-cap fibroatheroma and ruptured plaques in patients with coronary artery disease: an optical coherence tomographic study.

Sudhir Rathore1, Mitsuyasu Terashima, Hitoshi Matsuo, Yoshihisa Kinoshita, Masashi Kimura, Etsuo Tsuchikane, Kenya Nasu, Mariko Ehara, Yasushi Asakura, Osamu Katoh, Takahiko Suzuki.   

Abstract

OBJECTIVES: The purpose of this study was to assess the prevalence and to quantify the thin-cap fibroatheroma (TCFA) and ruptured plaques in patients with coronary artery disease using optical coherence tomography (OCT).
BACKGROUND: TCFA lesions are the most prevalent precursors of plaque rupture, and are responsible for acute coronary syndromes (ACS). There are limited data regarding the frequency and distribution of TCFA in diseased coronary arteries.
METHODS: Coronary artery OCT was performed in 78 vessels in 47 patients, with stable angina (SA) or ACS. OCT plaque characteristics were derived using criteria that had been validated earlier. TCFA was defined as rich in lipid (two or more quadrants) with thin fibrous cap (<65 μm). Comparison was made between SA and unstable angina, and culprit and nonculprit vessels.
RESULTS: There was a higher incidence of TCFA and plaque rupture (65 vs. 24%, P=0.003, and 40 vs. 15%, P=0.04) in ACS patients. This was reflected in a higher lipid pool (2.66 vs. 2.26 quadrants, P=0.04) and minimum fibrous cap thickness (52 vs. 74 μm, P=0.001) in ACS patients. The mean numbers of TCFA (2.5) were similar in patients with SA and ACS. However, the maximal length of TCFA (2.63 vs. 5.54 mm, P=0.026) and plaque rupture sites (P=0.046) were higher in ACS vessels. No relationship was found between baseline characteristics and TCFA incidence and plaque rupture. We identified ACS (P=0.002), higher mean lipid pool (P=0.002), longer TCFA length (P=0.007) and higher number of TCFA (P=0.02) as predictors of plaque rupture sites.
CONCLUSION: In this in-vivo study, we identified a higher incidence of longer TCFAs and plaque rupture sites associated with ACS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21191287     DOI: 10.1097/MCA.0b013e32833e1c36

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  6 in total

1.  Diagnosis of Thin-Capped Fibroatheromas in Intravascular Optical Coherence Tomography Images: Effects of Light Scattering.

Authors:  Jennifer E Phipps; Taylor Hoyt; Deborah Vela; Tianyi Wang; Joel E Michalek; L Maximilian Buja; Ik-Kyung Jang; Thomas E Milner; Marc D Feldman
Journal:  Circ Cardiovasc Interv       Date:  2016-07       Impact factor: 6.546

2.  Comparison of morphologic findings obtained by optical coherence tomography in acute coronary syndrome caused by vasospasm and chronic stable variant angina.

Authors:  Hwan-Cheol Park; Jeong Hun Shin; Woo Kyoung Jeong; Sung Il Choi; Soon-Gil Kim
Journal:  Int J Cardiovasc Imaging       Date:  2014-10-08       Impact factor: 2.357

Review 3.  Plaque assessment by coronary CT.

Authors:  Bálint Szilveszter; Csilla Celeng; Pál Maurovich-Horvat
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-18       Impact factor: 2.357

4.  Differences determined by optical coherence tomography volumetric analysis in non-culprit lesion morphology and inflammation in ST-segment elevation myocardial infarction and stable angina pectoris patients.

Authors:  Micheli Zanotti Galon; Zhao Wang; Hiram G Bezerra; Pedro Alves Lemos; Audrey Schnell; David L Wilson; Andrew M Rollins; Marco A Costa; Guilherme F Attizzani
Journal:  Catheter Cardiovasc Interv       Date:  2014-10-04       Impact factor: 2.692

5.  Optical Coherence Tomography and Fibrous Cap Characterization.

Authors:  Daniel Chamié; Zhao Wang; Hiram Bezerra; Andrew M Rollins; Marco A Costa
Journal:  Curr Cardiovasc Imaging Rep       Date:  2011-05-12

6.  Volumetric quantification of fibrous caps using intravascular optical coherence tomography.

Authors:  Zhao Wang; Daniel Chamie; Hiram G Bezerra; Hirosada Yamamoto; Jan Kanovsky; David L Wilson; Marco A Costa; Andrew M Rollins
Journal:  Biomed Opt Express       Date:  2012-05-16       Impact factor: 3.732

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.